Your browser doesn't support javascript.
loading
Congenital melanocytic nevi: where are we now? Part II. Treatment options and approach to treatment.
Ibrahimi, Omar A; Alikhan, Ali; Eisen, Daniel B.
Afiliação
  • Ibrahimi OA; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut, USA.
J Am Acad Dermatol ; 67(4): 515.e1-13; quiz 528-30, 2012 Oct.
Article em En | MEDLINE | ID: mdl-22980259
Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, dermabrasion, curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and lasers. Only low-level evidence supporting these approaches is available, and large randomized controlled trials have not been published. This article explores therapeutic controversies and makes recommendations based on the best available evidence.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Nevo Pigmentado Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Nevo Pigmentado Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article